Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Zeitlinger

Showing results (21-30 of 352) with videos related to

Pageof 36
Sort By:
The New England Journal of Medicine|September 3, 2025
Malnutrition in Older AdultsIris K Minichmayr, Markus Zeitlinger
Antibiotics (Basel, Switzerland)|December 24, 2021
Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time-Kill ApproachesWisse van Os, Markus Zeitlinger
Pharmaceutics|August 23, 2020
Use of Supplemented or Human Material to Simulate PD Behavior of Antibiotics at the Target Site In VitroAlina Nussbaumer-Pröll, Markus Zeitlinger
Clinical Pharmacokinetics|February 27, 2020
Systemic and Target-Site Pharmacokinetics of Antiparasitic AgentsValentin Al Jalali, Markus Zeitlinger
Clinical Pharmacokinetics|January 15, 2018
Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other GlycopeptidesValentin Al Jalali, Markus Zeitlinger
The Journal of Antimicrobial Chemotherapy|January 4, 2024
Target attainment of intravenous lefamulin for treatment of acute bacterial skin and skin structure infectionsWisse van Os, Markus Zeitlinger
Wiener Klinische Wochenschrift|October 20, 2025
Economic, cultural and social inequalities in potentially inappropriate medication-An Austrian perspectiveChristian Schoergenhofer, Thorsten Bischof, Markus Zeitlinger
The Journal of Antimicrobial Chemotherapy|June 27, 2018
Comment on: Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypassMartin Andreas, Markus Zeitlinger, Doris Hutschala
The Journal of Antimicrobial Chemotherapy|December 30, 2022
A narrative review of the intermediate category of the antimicrobial susceptibility test: relation with dosing and possible impact on antimicrobial stewardshipErlangga Yusuf, Markus Zeitlinger, Sylvain Meylan
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 6, 2019
Pharmacokinetic Imaging with Radiolabeled Molecularly Targeted Anticancer DrugsMartin Bauer, Markus Zeitlinger, Oliver Langer
Pageof 36

Showing results (21-30 of 352) with videos related to

Sort By:
Pageof 36
The New England Journal of Medicine|September 3, 2025
Malnutrition in Older AdultsIris K Minichmayr, Markus Zeitlinger
Antibiotics (Basel, Switzerland)|December 24, 2021
Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time-Kill ApproachesWisse van Os, Markus Zeitlinger
Pharmaceutics|August 23, 2020
Use of Supplemented or Human Material to Simulate PD Behavior of Antibiotics at the Target Site In VitroAlina Nussbaumer-Pröll, Markus Zeitlinger
Clinical Pharmacokinetics|February 27, 2020
Systemic and Target-Site Pharmacokinetics of Antiparasitic AgentsValentin Al Jalali, Markus Zeitlinger
Clinical Pharmacokinetics|January 15, 2018
Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other GlycopeptidesValentin Al Jalali, Markus Zeitlinger
The Journal of Antimicrobial Chemotherapy|January 4, 2024
Target attainment of intravenous lefamulin for treatment of acute bacterial skin and skin structure infectionsWisse van Os, Markus Zeitlinger
Wiener Klinische Wochenschrift|October 20, 2025
Economic, cultural and social inequalities in potentially inappropriate medication-An Austrian perspectiveChristian Schoergenhofer, Thorsten Bischof, Markus Zeitlinger
The Journal of Antimicrobial Chemotherapy|June 27, 2018
Comment on: Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypassMartin Andreas, Markus Zeitlinger, Doris Hutschala
The Journal of Antimicrobial Chemotherapy|December 30, 2022
A narrative review of the intermediate category of the antimicrobial susceptibility test: relation with dosing and possible impact on antimicrobial stewardshipErlangga Yusuf, Markus Zeitlinger, Sylvain Meylan
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 6, 2019
Pharmacokinetic Imaging with Radiolabeled Molecularly Targeted Anticancer DrugsMartin Bauer, Markus Zeitlinger, Oliver Langer
Pageof 36